Cargando…
MYC—Master Regulator of the Cancer Epigenome and Transcriptome
Overexpression of MYC is a hallmark of many human cancers. The MYC oncogene has long been thought to execute its neoplastic functions by acting as a classic transcription factor, deregulating the expression of a large number of specific target genes. However, MYC’s influence on many of these target...
Autores principales: | Poole, Candace J., van Riggelen, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5448016/ https://www.ncbi.nlm.nih.gov/pubmed/28505071 http://dx.doi.org/10.3390/genes8050142 |
Ejemplares similares
-
MYC deregulates TET1 and TET2 expression to control global DNA (hydroxy)methylation and gene expression to maintain a neoplastic phenotype in T-ALL
por: Poole, Candace J., et al.
Publicado: (2019) -
Targeting the MYC Oncogene in Burkitt Lymphoma through HSP90 Inhibition
por: Poole, Candace J., et al.
Publicado: (2018) -
FGFR1 fusion kinase regulation of MYC expression drives development of stem cell leukemia/lymphoma syndrome
por: Hu, Tianxiang, et al.
Publicado: (2018) -
DNMT3B overexpression contributes to aberrant DNA methylation and MYC-driven tumor maintenance in T-ALL and Burkitt’s lymphoma
por: Poole, Candace J., et al.
Publicado: (2017) -
A network of epigenomic and transcriptional cooperation encompassing an epigenomic master regulator in cancer
por: Wilson, Stephen, et al.
Publicado: (2018)